GEN News Highlights: Nov 26, 2009

President Obama Establishes New Bioethics Commission

(Page 1 of 1)

    President Barack Obama has created a new Presidential Commission for the Study of Bioethical Issues and appointed Amy Gutmann, president of the University of Pennsylvania, to serve as chair and James W. Wagner, president of Emory University, to serve as vice chair. The committee will ultimately be composed of 13 members, it is unclear when the other 11 will be named.

    This new commission will replace the council that advised the Bush administration, which President Obama disbanded earlier this year.

    The President’s Commission for the Study of Bioethical Issues will advise the President on bioethical issues that may emerge from advances in biomedicine and related areas of science and technology.  The Commission will work with the goal of identifying and promoting policies and practices that ensure scientific research, healthcare delivery, and technological innovation are conducted in an ethically responsible manner. 

    Dr. Amy Gutmann, in addition to being president of UPenn, is also the Christopher H. Browne distinguished professor of political science in the school of arts and sciences and holds secondary appointments in communications, education, and philosophy. She was previously provost at Princeton University, where she was the founding director of the University Center for Human Values—a multidisciplinary center that fosters greater research and discourse on ethics and human values. 

    At Emory, Dr. Wagner has championed the role of ethics in the mission of the university by enhancing the prominence of Emory’s university-wide Center for Ethics and including ethical engagement as one of the six pillars of the University’s strategic vision.


Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll